Documente Academic
Documente Profesional
Documente Cultură
OF
PHARMACEUTICAL
SECTOR
No STOCK NAME PRICE P/E EPS
1 Cipla 602.25 33.09 18.200363
2 Pirmal enter 2541.75 88.46 28.733326
3 cadila Health 407.9 38.1 10.706037
4 Aurobindo pharma 609.3 19.65 31.007634
5 Lupin 898.3 30.33 29.61754
6 Dr.Reddy lab 239.7 70.06 3.4213531
7 Devis lab 1092.9 33.23 32.888956
8 Alkem lab 1957.85 32.74 59.799939
9 Torrent pharma 1487.5 52.42 28.376574
10 Gloxosmithkline 2792.85 67.15 41.591214
11 Glenmark 586.1 16.44 35.650852
12 Natco pharma 832.1 37.84 21.989958
13 Abbott india 6913.75 36.54 189.21045
14 Jubilant Iife 739.85 44.85 16.496098
15 Pfizzer 2591.85 33.08 78.350967
16 Sanofi india 5183.6 34.3 151.12536
17 Ajanta pharma 1066.8 22.01 48.468878
18 Eris life 734.6 34.12 21.529894
19 Alembic pharma 500.7 26.38 18.980288
20 IPCA lab 676.9 36.68 18.454198
21 Dr.lal path lab 858.85 43.1 19.926914
22 Laurus lab 488.75 29.67 16.472868
UNDERVALUED OVERVALUED
Cipla Pirmal enter
cadila Health Dr.Reddy lab
Aurobindo pharma Torrent pharma
Lupin Gloxosmithkline
Devis lab Jubilant Iife
Alkem lab Dr.lal path lab
Glenmark
Natco pharma
Abbott india
Pfizzer
Sanofi india
Ajanta pharma
Eris life
Alembic pharma
IPCA lab
Laurus lab
UNDERVALUED STOCK
STOCK NAME 2016 2017
PROFIT REVENUE PROFIT REVENUE
CIPLA 1462.3 12162.67 974.94 11055.09
CADILA 2037.5 7139.7 661.9 3960.8
AUROBINDO 1626.7 9496.13 1706.76 9711.68
LUPIN 2330.87 11579.41 3141.33 12899.93
DIVIS LAB 1107.96 3792.46 1053.27 4121.45
ALKEM LAB 700.19 4236.38 883.16 4996.97
GLENMARK 1484.27 6302.45 2140.61 7982.27
NATCO PHARMA 176.5 1082.1 494.8 1987.9
ABBOTT INDIA 255.25 2665.09 276.65 2960.2
PFIZZER 304.98 2057.33 336.78 2213.61
SANOFI INDIA 297 2474.6 326 2473.1
AJANTA PHARMA 499.81 1882.26 427.52 1951.31
ERIS LIFE 137.97 606.62 242.57 699.35
ALEMBIC PHARMA 698.14 3093.2 430.63 3036.22
IPCA INDIA 92.52 2809.07 188.29 3124.59
LAURUS 143.57 1813.49 202.57 1958.47
OVERVALUED STOCKS